Former U.S. Representative Cathy McMorris Rodgers is intensifying her advocacy for a sweeping health care price transparency bill, urging her former congressional colleagues to pass the Patients Deserve Price Tags Act. Rodgers, who represented Washington's 5th District, argues that requiring upfront pricing throughout the health care system is the foundational reform needed to curb runaway costs and empower patients.

A Personal and Policy Imperative

Rodgers, who made the legislation a top priority in her final congressional term, says leaving office has only deepened her commitment. The push follows a recent personal experience in an emergency room with her husband, a Navy veteran. While grateful for care received through Tricare, she notes most American families "fly blind on cost," facing potentially devastating bills after seeking necessary treatment. This lack of clarity, she contends, makes navigating the system unnecessarily stressful and expensive.

Read also
Healthcare
Bipartisan Senate Group Proposes $35 Insulin Cap for Privately Insured Americans
Four senators from both parties unveiled the INSULIN Act, which would limit monthly out-of-pocket insulin costs to $35 for patients with private insurance and create a pilot program for the uninsured.

The Case for Transparency

The proposed legislation would mandate that health care providers disclose prices beforehand, allowing patients to compare costs and make informed decisions. Rodgers cites a study by 3 Axis Advisors revealing extreme price variations for identical treatments, such as chemotherapy costing between $12,000 and $43,000. She argues this opacity enables overcharging and prevents market competition from lowering prices.

The former lawmaker also frames the issue as critical for preserving employer-sponsored insurance. With average annual family premiums now at $27,000, according to KFF, escalating costs are eroding worker wages and forcing small businesses to drop coverage. The bill would grant employers access to claims data to identify price gouging and overbilling, potentially allowing them to design more affordable plans.

Broad Economic and Bipartisan Support

Rodgers points to analysis suggesting price transparency could save the U.S. economy $1 trillion annually, a figure endorsed by 40 economists across the ideological spectrum. She emphasizes that the issue commands support from 90% of Americans, transcending typical partisan divides. "It isn't left versus right — it is a matter of fairness and affordability," she writes.

The legislation also aims to benefit those on government plans like Medicare, Medicaid, and Tricare. By revealing cash prices, it would allow patients to weigh the trade-off between waiting for an appointment within their network or paying directly for quicker access, potentially reducing wait times system-wide. This comes as other health care pressures mount, including reports that ACA enrollees are sacrificing essentials due to rising costs and university mental health services are overwhelmed.

A Call to Action

Despite the bill's previous failure to reach the president's desk, Rodgers is calling for renewed bipartisan effort. She argues that in a time of broader economic strain—including political fallout from energy price spikes and global conflict—addressing health care affordability is more urgent than ever. "It is a fight worth continuing, and I intend to see it through," she concludes, positioning price transparency not as a niche policy issue but as a central economic and fairness concern for American families.